Issue 3/1997
Content (9 Articles)
Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer
James N. Ingle, Carl G. Kardinal, Vera J. Suman, Michael H. Veeder, Paul L. Schaefer, Ronnie J. Kirschling, James A. Mailliard
Feasibility of obtaining breast epithelial cells from healthy women for studies of cellular proliferation
Naomi A. Miller, Michael Thomas, Lisa J. Martin, David W. Hedley, Stefany Michal, Norman F. Boyd
Serum concentration of tumor necrosis factor in patients with breast cancer
Shyr-Ming Sheen-Chen, Wei-Jen Chen, Hock-Liew Eng, Fong-Fu Chou
Prognostic significance of etiological risk factors in early breast cancer
Leo J. Schouten, Pierre S.G.J. Hupperets, Jos J. Jager, Lex Volovics, Jacques A. Wils, André L.M. Verbeek, Geert H. Blijham
Hospital-related differences in breast cancer management
Nils K. Raabe, Rolf Kaaresen, Sophie D. Fossaa
Antineoplastic activity of sterically stabilized alkylphosphocholine liposomes in human breast carcinomas
D. Arndt, R. Zeisig, I. Eue, B. Sternberg, I. Fichtner
Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice
Richard J. Hambly, John A. Double, Michael J. Thompson, Mike C. Bibby
Guidelines for systemic therapy of early stage breast cancer
Joanne L. Blum, Stephen E. Jones, Joseph W. Fay, Neil Senzer, Robert G. Mennel